United Therapeutics Corp. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
689
696
954
1,051
927
1,416
Total Accounts Receivable
126
162
193
215
297
176
Inventories
48
67
81
100
108
101
Other Current Assets
46
49
47
60
116
75
Total Current Assets
909
974
1,275
1,425
1,448
1,768
Net Property, Plant & Equipment
465
478
496
489
546
700
Total Investments and Advances
484
206
175
176
563
448
Intangible Assets
14
29
28
34
46
171
Other Assets
22
15
17
24
164
219
Total Assets
2,088
1,884
2,219
2,357
2,899
3,454
ST Debt & Current Portion LT Debt
282
126
5
-
-
Accounts Payable
7
7
8
8
8
Other Current Liabilities
399
371
428
324
436
Total Current Liabilities
688
504
441
333
445
Long-Term Debt
4
-
-
-
250
Provision for Risks & Charges
7
12
9
10
13
Deferred Taxes
193
182
193
178
113
Other Liabilities
85
103
135
121
51
Total Liabilities
783
619
619
495
778
Common Equity (Total)
1,259
1,242
1,589
1,851
2,102
Total Shareholders' Equity
1,270
1,253
1,599
1,862
2,121
Total Equity
1,270
1,253
1,599
1,862
2,121
Liabilities & Shareholders' Equity
2,088
1,884
2,219
2,357
2,899
Non-Equity Reserves
-
34
12
-
-
Preferred Stock (Carrying Value)
11
11
11
11
19
About United Therapeutics
View Profile
